BISMUTH SUBSALICYLATE/ANTIBIOTIC COMBO FOR PEPTIC ULCERS
This article was originally published in The Tan Sheet
Executive Summary
BISMUTH SUBSALICYLATE/ANTIBIOTIC COMBO FOR PEPTIC ULCERS with the Helicobacter pylori bacterium was one of the treatments found effective by a National Institutes of Health consensus panel on Feb. 9. Specific treatments that have shown efficacy against H. pylori in clinical studies, according to the panel, include triple therapy with bismuth subsalicylate (Procter & Gamble's Pepto- Bismol), tetracycline and metronidazole; a triple regimen with metronidazole, amoxicillin and an H2 receptor antagonist; and double therapy with amoxicillin and Rx proton pump inhibitor omeprazole (Merck's Prilosec).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning